Marine Microalgal Products with Activities against Age-Related Cardiovascular Diseases.
Nova YurikaEleonora MontuoriChiara LauritanoPublished in: Marine drugs (2024)
Heart disease is one of the leading causes of death worldwide, and it is estimated that 17.9 million people die of it each year. The risk factors for cardiovascular diseases are attributable to an unhealthy and sedentary lifestyle, poor nutrition, stress, genetic predisposition, diabetes, obesity, and aging. Marine microalgae have been the subject of numerous studies for their potential activity against several human diseases. They produce a plethora of primary and secondary metabolites such as essential nutrients, vitamins, pigments, and omega-3 fatty acid. Many of these molecules have antioxidant properties and have been shown to play a role in the prevention of heart diseases. The aim of this review is to summarize recent studies on the discovery of marine microalgal compounds and bioactivities for cardiovascular diseases, including in vitro and in vivo studies, showing and discussing recent discoveries and trends. The most promising results were found for microalgal polysaccharides, peptides and carotenoids. In conclusion, the overall data summarized here show that microalgae-based supplementation has the potential to improve age-related cardiovascular diseases and we expect more clinical studies in the future.
Keyphrases
- cardiovascular disease
- type diabetes
- physical activity
- case control
- cardiovascular events
- metabolic syndrome
- cardiovascular risk factors
- fatty acid
- endothelial cells
- insulin resistance
- small molecule
- heart failure
- oxidative stress
- weight loss
- ms ms
- atrial fibrillation
- electronic health record
- genome wide
- pulmonary hypertension
- big data
- adipose tissue
- weight gain
- current status
- anti inflammatory
- anaerobic digestion
- coronary artery disease
- artificial intelligence
- risk assessment
- single cell